Deep Vein Thrombosis Treatments

Find Deep Vein Thrombosis Treatments

Generic Name

Enoxaparin

Brand Names

Enoxiluv, Lovenox

FDA approval date: March 29, 1993

Classification: Low Molecular Weight Heparin

Form: Injection, Kit

What is Enoxiluv (Enoxaparin)?

Enoxaparin sodium injection, USP is a low molecular weight heparin indicated for: Prophylaxis of deep vein thrombosis in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness. For first aid to decrease germs in minor cuts scrapes burns For preparation of the skin prior to injection.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX)

Enrollment Status: Recruiting

Publish Date: June 17, 2026

Intervention Type: Drug

Study Phase: Phase 3

Summary: This study is researching an experimental drug called REGN7508 (called study drug). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery. The study is looking at several other r...

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk. An Open-label, Randomized, Controlled Trial Comparing Two Strategies With or Without Pharmacological Thromboprophylaxis

Enrollment Status: Recruiting

Publish Date: June 10, 2026

Intervention Type: Drug

Study Phase: Phase 4

Summary: Venous thromboembolism (VTE) is currently the second cause of death in women of reproductive age worldwide. The incidence of VTE during pregnancy is 1.2 to 1.4/1000 women, half of VTE occurring during postpartum and as PE in majority of cases, accounting for 8.8% of maternal deaths. Majority of postpartum VTE occurs in women with one or more moderate risk factors (obesity, caesarean section, postp...

Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill Children

Who is this study for: Patients with Deep Vein Thrombosis

Enrollment Status: Recruiting

Publish Date: June 08, 2026

Intervention Type: Drug

Study Drug: Enoxaparin

Study Phase: Phase 2/Phase 3

Summary: The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

View All Clinical Trials